comprehensive -WSS

comprehensive

author：explore 2025-10-01 15:30:43 - browse：28

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： With Wegovy coverage, Medicare patients may face high costs

WSS

Yancopoulos of Regeneron works to expand Dupixent success

Erich Jarvis studies song birds to learn about human stuttering

Mirador, a new biotech startup, launches with $400 million

Chinese researcher claims birth of first gene

Akili, maker of video game for ADHD, to be acquired for 34 million

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

leisure time

comprehensive

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

6 surprising facts about sugar

What does generative AI mean for health care? We asked experts

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Cancer drug shortages should be causing more outrage

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Jerome Adams on the need for new antivirals for Covid

Pregnancy ages women, but effects reverse after delivery

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

U.K. officials, researchers try to ease path for bespoke genetic treatments

hotspot

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Scientists successfully use ultrasound imaging to map brain activity

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Medical devices makers are asking for forgiveness, not permission

Chinese researcher claims birth of first gene

focus

explore

entertainment

knowledge